NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced the appointment of Peter Greenleaf to the Company’s Board of Directors, succeeding Tony Zook.
